These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20097930)

  • 1. Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia.
    Sundaram M; Zhong S; Bou Khalil M; Zhou H; Jiang ZG; Zhao Y; Iqbal J; Hussain MM; Figeys D; Wang Y; Yao Z
    J Lipid Res; 2010 Jun; 51(6):1524-34. PubMed ID: 20097930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of lipid precursors within the microsomal lumen.
    Qin W; Sundaram M; Wang Y; Zhou H; Zhong S; Chang CC; Manhas S; Yao EF; Parks RJ; McFie PJ; Stone SJ; Jiang ZG; Wang C; Figeys D; Jia W; Yao Z
    J Biol Chem; 2011 Aug; 286(31):27769-80. PubMed ID: 21676879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions.
    Sundaram M; Zhong S; Bou Khalil M; Links PH; Zhao Y; Iqbal J; Hussain MM; Parks RJ; Wang Y; Yao Z
    J Lipid Res; 2010 Jan; 51(1):150-61. PubMed ID: 19622837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human apolipoprotein C-III - a new intrahepatic protein factor promoting assembly and secretion of very low density lipoproteins.
    Yao Z
    Cardiovasc Hematol Disord Drug Targets; 2012 Dec; 12(2):133-40. PubMed ID: 23030451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of microsomal triglyceride transfer protein is essential for accumulation of triglyceride within microsomes in McA-RH7777 cells. A unified model for the assembly of very low density lipoproteins.
    Wang Y; Tran K; Yao Z
    J Biol Chem; 1999 Sep; 274(39):27793-800. PubMed ID: 10488124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
    Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
    J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of triacylglycerol-poor VLDL particles from McA-RH7777 cells expressing human hepatic lipase.
    Bamji-Mirza M; Sundaram M; Zhong S; Yao EF; Parks RJ; Yao Z
    J Lipid Res; 2011 Mar; 52(3):540-8. PubMed ID: 21189265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.
    Sehayek E; Eisenberg S
    J Biol Chem; 1991 Sep; 266(27):18259-67. PubMed ID: 1917954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of cytosolic triacylglycerol recruitment for very low density lipoprotein assembly by inactivation of microsomal triglyceride transfer protein results in a delayed removal of apoB-48 and apoB-100 from microsomal and Golgi membranes of primary rat hepatocytes.
    Hebbachi AM; Brown AM; Gibbons GF
    J Lipid Res; 1999 Oct; 40(10):1758-68. PubMed ID: 10508195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr.
    Liu H; Labeur C; Xu CF; Ferrell R; Lins L; Brasseur R; Rosseneu M; Weiss KM; Humphries SE; Talmud PJ
    J Lipid Res; 2000 Nov; 41(11):1760-71. PubMed ID: 11060345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia.
    Campos H; Perlov D; Khoo C; Sacks FM
    J Lipid Res; 2001 Aug; 42(8):1239-49. PubMed ID: 11483625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice.
    Aalto-Setälä K; Weinstock PH; Bisgaier CL; Wu L; Smith JD; Breslow JL
    J Lipid Res; 1996 Aug; 37(8):1802-11. PubMed ID: 8864964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.
    Khetarpal SA; Zeng X; Millar JS; Vitali C; Somasundara AVH; Zanoni P; Landro JA; Barucci N; Zavadoski WJ; Sun Z; de Haard H; Toth IV; Peloso GM; Natarajan P; Cuchel M; Lund-Katz S; Phillips MC; Tall AR; Kathiresan S; DaSilva-Jardine P; Yates NA; Rader DJ
    Nat Med; 2017 Sep; 23(9):1086-1094. PubMed ID: 28825717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
    Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
    J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects.
    Berman M; Hall M; Levy RI; Eisenberg S; Bilheimer DW; Phair RD; Goebel RH
    J Lipid Res; 1978 Jan; 19(1):38-56. PubMed ID: 202659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoc-III-beta-galactosidase hybrid distinguishes between VLDL and LDL phospholipids.
    Trieu VN; McConathy WJ
    Biochem Biophys Res Commun; 1995 Jun; 211(3):754-60. PubMed ID: 7598703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential metabolism of human VLDL according to content of ApoE and ApoC-III.
    Tomiyasu K; Walsh BW; Ikewaki K; Judge H; Sacks FM
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1494-500. PubMed ID: 11557678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Humphries S; Turner PR; Masana L
    J Lipid Res; 1997 Jun; 38(6):1061-9. PubMed ID: 9215535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.